PRTA
NASDAQ
$8.67
Prothena Corporation plc (PRTA)
Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases in the United States. The company is headquartered in Dublin, Ireland.
Sector:
Healthcare
Industry:
Biotechnology
Target: $21.40 (+146.83%)
Market Cap
$447M
Revenue 5Y CAGR
+131.47%
Profit Margin
64.1%
Free Cash Flow Yield
-18.18%
Price Chart
Valuation
Market Cap$447M
Forward P/E10.63
P/S7.62
P/B1.45
Profitability
Total Revenue (TTM)$58M
Gross Profit (TTM)-$39M
EBITDA-$118M
Profit Margin64.1%
Operating Margin58.8%
EPS-$2.80
Financial Health
Free Cash Flow Yield-18.18%
Growth & Risk
EPS 5Y CAGR-1.54%
Revenue 5Y CAGR+131.47%
FCF 5Y CAGR-2.19%
Beta (5Y)0.89
Sharpe Ratio0.76